# Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa

> **NCT03929835** · PHASE2 · WITHDRAWN · sponsor: **TO Pharmaceuticals**

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Cannabis oil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03929835
- **Lead sponsor:** TO Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** withdrawn due to COVID-19
- **Last updated:** 2021-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03929835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03929835, "Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03929835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*